Report cover image

U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel)-

Publisher Coherent Market Insights
Published Sep 20, 2022
Length 102 Pages
SKU # CMI17440809

Description

U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

A medical food is specifically formulated for patients, who require medical food as a major part of their dietary supplement during treatment. They are custom-made liquid solutions created with the sole purpose of curing persons suffering from various illnesses. Professionals provide the designed meal to people suffering from various illnesses. It is a specially prepared diet that provides patients with adequate nutrients.

Medical foods are available in different forms such as powders, liquids, and even gum. Moreover, medical foods are more commonly used to treat chronic conditions and diseases through long-term use in an outpatient setting. Manufacturers are developing products for new illness indications, fueling growth of the medical food market. Medical food is specifically tailored to meet the nutritional and metabolic demands of those suffering from a specific illness.

Market Dynamics

Medical foods are also used in the treatment of other gastrointestinal diseases such as diarrhea, constipation, gastroenteritis, peptic ulcer diseases, and colorectal cancer, which is expected to propel market growth over the forecast period. Moreover, the increasing geriatric population suffering from several chronic and neurogenic disorders such as dementia, stroke, multiple sclerosis, and difficulty in swallowing requires specific dietary management, which, in turn, is expected to drive the market growth over the forecast period. For instance in July 2019, Georgetown University entered into a collaboration with National Center for Complementary and Integrative Health (NCCIH), University of Maryland, a United States government agency which explores complementary and alternative medicine, initiated early phase 1 clinical trial to demonstrate the mechanisms of preventing antibiotic-associated diarrhea and the role of probiotics.

Key features of the study:
  • This report provides in-depth analysis of the U.S. Medical Foods market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. Medical Foods market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. Medical Foods market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. Medical Foods market
Detailed Segmentation:
  • U.S. Medical Foods Market, By Food Type:
  • Prebiotics
  • Probiotics
  • Probiotic Foods
  • Probiotic Supplements
  • Food Supplements
  • U.S. Medical Foods Market, By Disease Indication:
  • Inflammatory Bowel Disease
  • Ulcerative Colitis
  • Cohn’s Disease
  • Irritable Bowel Syndrome
  • Others
  • U.S. Medical Foods Market, By Distribution Channel:
  • Hospitals
  • Retail Channel
  • Online Channel
  • Company Profiles
  • Enterome SA*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Yakult Honsha Co., Ltd.
  • Abbott
  • ExeGi Pharma, LLC.
  • VSL Pharmaceuticals, Inc.
  • Entera Health, Inc.
  • Meiji Holdings Co., Ltd.
  • Danone
  • Nestlé S.A.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

102 Pages
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Food Type  Market Snapshot, By Disease Indication  Market Snapshot, By Distribution Channel o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Recent Product Launch o Epidemiology o Major Brand Analysis o Regulatory Scenario o PEST Analysis 4. U.S. Medical Foods Market- Impact of Coronavirus (Covid-19) Pandemic o Overall Impact o Impact on Supply and Demand o COVID-19 Impact on the market 5. U.S. Medical Foods Market, By Food Type, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Prebiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Probiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Probiotic Foods o Probiotic Supplements o Food Supplements  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 6. U.S. Medical Foods Market, By Disease Indication, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Inflammatory Bowel Disease  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Ulcerative Colitis o Cohn’s Disease o Irritable Bowel Syndrome  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 7. U.S. Medical Foods Market, By Distribution Channel, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Hospitals  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Retail channel  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Online Channel  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 8. Competitive Landscape o Enterome SA  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Yakult Honsha Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Abbott  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o ExeGi Pharma, LLC.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o VSL Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Entera Health, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Meiji Holdings Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Danone  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Nestlé S.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us *Browse 27 market data tables and 31 figures on "U.S. Medical Foods Market” – U. S. forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us